Cardinal Health (CAH) analyst forecast and price target
Analyst forecast
Consensus of 21 analyst ratings
Based on 12 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Initiated Coverage | Outperform | $276.00 | Aug 19, 2026 |
| Barclays | Maintained | Overweight | $275.00 from $258.00 | Aug 13, 2026 |
| JP Morgan | Maintained | Neutral | $260.00 from $215.00 | Aug 13, 2026 |
| TD Cowen | Maintained | Buy | $280.00 from $275.00 | Aug 13, 2026 |
| Baird | Maintained | Outperform | $274.00 from $251.00 | Aug 12, 2026 |
| Wells Fargo | Maintained | Overweight | $277.00 from $245.00 | Aug 12, 2026 |
| UBS | Maintained | Buy | $280.00 from $274.00 | Aug 12, 2026 |
| Morgan Stanley | Maintained | Overweight | $265.00 from $255.00 | Aug 12, 2026 |
| Mizuho | Maintained | Outperform | $250.00 from $240.00 | Aug 12, 2026 |
| Evercore ISI Group | Maintained | Outperform | $270.00 from $265.00 | Aug 12, 2026 |
| Citigroup | Maintained | Buy | $280.00 from $265.00 | Aug 12, 2026 |
| Citigroup | Maintained | Buy | $265.00 from $245.00 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $240.00 from $235.00 | Jul 23, 2026 |
| UBS | Maintained | Buy | $274.00 from $260.00 | Jul 20, 2026 |
| TD Cowen | Maintained | Buy | $275.00 from $255.00 | Jul 9, 2026 |
| B of A Securities | Maintained | Buy | $260.00 from $240.00 | Jul 2, 2026 |
| JP Morgan | Maintained | Neutral | $215.00 from $243.00 | May 4, 2026 |
| Wells Fargo | Maintained | Overweight | $245.00 from $256.00 | May 1, 2026 |
| TD Cowen | Maintained | Buy | $255.00 from $251.00 | May 1, 2026 |
| Citigroup | Maintained | Buy | $245.00 from $249.00 | May 1, 2026 |
Frequently asked questions
What is the price target for CAH stock?
The average 12-month analyst price target for Cardinal Health (CAH) is $270.58, with a high estimate of $280.00 and a low of $250.00, across 12 analysts.
Is CAH a buy, sell, or hold?
Analysts covering Cardinal Health currently average a Buy rating: 18 buy, 3 hold and 0 sell, from 21 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CAH?
The average price target of $270.58 implies 15.33% upside from the last price of $234.62.
What is the latest analyst rating on CAH?
On Aug 19, 2026, RBC Capital initiated coverage of Cardinal Health at Outperform with a price target of $276.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.